CompletedPhase 4

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

United States106 participantsStarted 2007-09

Plain-language summary

This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of open-angle glaucoma (pseudoexfoliative or pigmentary glaucomas are allowed) or ocular hypertension Exclusion Criteria: * Known contraindication to latanoprost, bimatoprost or travoprost * Uncontrolled systemic disease * Active ocular disease other than glaucoma or ocular hypertension * Pregnant or lactating women or women of childbearing potential NOT utilizing a medically acceptable form of birth control

What they're measuring

Change From Baseline in Mean Conjunctival Hyperemia Scores at Month 3

Timeframe: Baseline, Month 3

Trial details

NCT IDNCT00539526

SponsorAllergan

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-07

Results submitted2011-09-22

View on ClinicalTrials.gov More Open Angle Glaucoma trials